2013 Form 10-K Financial Statement
#000114420414012919 Filed on March 03, 2014
Income Statement
Concept | 2013 | 2012 Q4 | 2012 Q3 |
---|---|---|---|
Revenue | $123.0K | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | $190.0K | ||
YoY Change | |||
Gross Profit | -$67.00K | ||
YoY Change | |||
Gross Profit Margin | -54.47% | ||
Selling, General & Admin | $8.926M | $1.850M | $1.453M |
YoY Change | 48.45% | 74.53% | 22.62% |
% of Gross Profit | |||
Research & Development | $4.923M | $1.210M | $696.0K |
YoY Change | 32.13% | 53.16% | -27.65% |
% of Gross Profit | |||
Depreciation & Amortization | $130.0K | $30.00K | $40.00K |
YoY Change | 0.0% | 0.0% | 33.33% |
% of Gross Profit | |||
Operating Expenses | $13.85M | $3.057M | $2.149M |
YoY Change | 42.2% | 65.24% | 0.09% |
Operating Profit | -$14.09M | -$3.057M | -$2.149M |
YoY Change | 44.68% | 0.09% | |
Interest Expense | $9.000K | $80.00K | |
YoY Change | 700.0% | ||
% of Operating Profit | |||
Other Income/Expense, Net | $189.0K | -$40.00K | $9.000K |
YoY Change | 166.2% | 50.0% | |
Pretax Income | -$13.90M | -$3.020M | -$2.140M |
YoY Change | 43.78% | 64.13% | -0.05% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$13.90M | -$3.016M | -$2.140M |
YoY Change | 43.78% | 82.79% | -0.05% |
Net Earnings / Revenue | -11301.63% | ||
Basic Earnings Per Share | -$0.29 | -$0.06 | -$0.04 |
Diluted Earnings Per Share | -$0.29 | -$0.06 | -$0.04 |
COMMON SHARES | |||
Basic Shares Outstanding | 47.76M shares | 45.86M shares | 47.52M shares |
Diluted Shares Outstanding | 47.76M shares | 47.52M shares |
Balance Sheet
Concept | 2013 | 2012 Q4 | 2012 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $26.07M | $27.42M | $29.32M |
YoY Change | -4.92% | -23.17% | -22.15% |
Cash & Equivalents | $12.34M | $7.476M | $29.32M |
Short-Term Investments | $13.73M | $19.95M | |
Other Short-Term Assets | $820.0K | $270.0K | $360.0K |
YoY Change | 164.52% | -6.9% | -16.28% |
Inventory | $250.0K | $220.0K | |
Prepaid Expenses | |||
Receivables | $190.0K | $10.00K | |
Other Receivables | $120.0K | $70.00K | |
Total Short-Term Assets | $27.45M | $27.99M | $29.84M |
YoY Change | -1.93% | -22.52% | -21.66% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $940.0K | $1.052M | $1.076M |
YoY Change | -10.48% | 0.77% | 7.6% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $240.0K | $10.00K | |
YoY Change | 2300.0% | ||
Total Long-Term Assets | $1.180M | $1.068M | $1.076M |
YoY Change | 11.32% | 2.3% | 7.6% |
TOTAL ASSETS | |||
Total Short-Term Assets | $27.45M | $27.99M | $29.84M |
Total Long-Term Assets | $1.180M | $1.068M | $1.076M |
Total Assets | $28.63M | $29.06M | $30.91M |
YoY Change | -1.45% | -21.83% | -20.92% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $270.0K | $994.0K | $228.0K |
YoY Change | -72.73% | 1775.47% | 356.0% |
Accrued Expenses | $540.0K | $413.0K | $459.0K |
YoY Change | 31.71% | -13.42% | -52.68% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.110M | $1.424M | $687.0K |
YoY Change | -21.83% | 168.68% | -38.66% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $9.600M | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $10.00K | |
YoY Change | -100.0% | ||
Total Long-Term Liabilities | $9.600M | $10.00K | $0.00 |
YoY Change | 95900.0% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.110M | $1.424M | $687.0K |
Total Long-Term Liabilities | $9.600M | $10.00K | $0.00 |
Total Liabilities | $10.71M | $1.429M | $690.0K |
YoY Change | 654.23% | 169.62% | -38.39% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$335.2M | -$332.2M | |
YoY Change | 2.97% | ||
Common Stock | $362.9M | $362.4M | |
YoY Change | 0.19% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $17.92M | $27.63M | $30.23M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $28.63M | $29.06M | $30.91M |
YoY Change | -1.45% | -21.83% | -20.92% |
Cashflow Statement
Concept | 2013 | 2012 Q4 | 2012 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$13.90M | -$3.016M | -$2.140M |
YoY Change | 43.78% | 82.79% | -0.05% |
Depreciation, Depletion And Amortization | $130.0K | $30.00K | $40.00K |
YoY Change | 0.0% | 0.0% | 33.33% |
Cash From Operating Activities | -$13.68M | -$1.840M | -$1.820M |
YoY Change | 94.34% | -2.65% | -1.09% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $23.00K | -$20.00K | -$20.00K |
YoY Change | -84.35% | -75.0% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $6.280M | -$19.99M | |
YoY Change | -131.42% | ||
Cash From Investing Activities | $6.253M | -$20.00M | -$20.00K |
YoY Change | -131.06% | 24900.0% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $12.29M | 0.000 | 0.000 |
YoY Change | -1283.91% | -100.0% | |
NET CHANGE | |||
Cash From Operating Activities | -$13.68M | -1.840M | -1.820M |
Cash From Investing Activities | $6.253M | -20.00M | -20.00K |
Cash From Financing Activities | $12.29M | 0.000 | 0.000 |
Net Change In Cash | $4.864M | -21.84M | -1.840M |
YoY Change | -117.24% | 1003.03% | 0.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$13.68M | -$1.840M | -$1.820M |
Capital Expenditures | $23.00K | -$20.00K | -$20.00K |
Free Cash Flow | -$13.70M | -$1.820M | -$1.800M |
YoY Change | 90.69% | 0.55% | -2.17% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2011 | acur |
Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
|
0 | USD |
CY2012 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
CY2012 | acur |
Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
|
0 | USD |
CY2013 | acur |
Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
|
250000 | USD |
CY2011 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
0 | USD |
CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
0 | USD |
CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
194000 | USD |
CY2011 | us-gaap |
Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
|
0 | USD |
CY2012 | us-gaap |
Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
|
0 | USD |
CY2013 | us-gaap |
Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
|
84000 | USD |
CY2011 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
0 | USD |
CY2012 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
219000 | USD |
CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
282000 | USD |
CY2011 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
141000 | USD |
CY2012 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
-110000 | USD |
CY2013 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
-43000 | USD |
CY2011 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
33000 | USD |
CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
16000 | USD |
CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
358000 | USD |
CY2013 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
186000 | USD |
CY2011 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
CY2011 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
0 | USD |
CY2012 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
0 | USD |
CY2013 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-6000 | USD |
CY2012 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
20306000 | USD |
CY2013 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
7611000 | USD |
CY2011 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
320000 | USD |
CY2013 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
13887000 | USD |
CY2011 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
131000 | USD |
CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
147000 | USD |
CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
23000 | USD |
CY2011 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-209000 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-20133000 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
6253000 | USD |
CY2011 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-131000 | USD |
CY2012 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-64000 | USD |
CY2011 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | USD |
CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-720000 | USD |
CY2011 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
12312000 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7038000 | USD |
CY2011 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
53000 | USD |
CY2012 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
941000 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-13678000 | USD |
CY2011 | us-gaap |
Interest Paid
InterestPaid
|
26000 | USD |
CY2012 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2013 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2011 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
-284000 | USD |
CY2012 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
108000 | USD |
CY2013 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
42000 | USD |
CY2011 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
11640000 | USD |
CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-28209000 | USD |
CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
4864000 | USD |
CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24045000 | USD |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
35685000 | USD |
CY2011 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
217000 | USD |
CY2012 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
9000 | USD |
CY2013 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
9000 | USD |
CY2011 | us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
5000 | USD |
CY2012 | us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
1000 | USD |
CY2013 | us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
1000 | USD |
CY2011 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1839000 | USD |
CY2012 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1048000 | USD |
CY2013 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
716000 | USD |
CY2011 | acur |
Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
|
0 | USD |
CY2012 | acur |
Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
|
0 | USD |
CY2013 | acur |
Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
|
-3328000 | USD |
CY2011 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-541000 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1038000 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12289000 | USD |
CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> </font> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">We invest our excess cash in accordance with the investment policy</font> <font style="FONT-SIZE: 10pt">approved by our Board of Directors</font> <font style="COLOR: black; FONT-SIZE: 10pt"> that seeks a combination of both liquidity and safety of principal, such as investments in instruments issued by the United States government and investment grade corporate bonds.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">Our accounts receivable arise from our product sales of Nexafed® and represents amounts due from wholesalers in the health care and pharmaceuticals industries and from chain drug stores. The Company has performed a credit evaluation of its customers and may maintain an allowance for potentially uncollectable accounts. We have not experienced any losses on uncollectable accounts.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> </font> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Sales to certain of our customers accounted for 10% or more of our annual net revenues, whether recognized or deferred, during 2013 as illustrated below: <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 50%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Customer</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="36%"> <div>Rite Aid Corporation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>52</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Cardinal Health, Inc.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>15</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2013 | dei |
Document Type
DocumentType
|
10-K | |
CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2013 | dei |
Trading Symbol
TradingSymbol
|
ACUR | |
CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
48847737 | shares |
CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
36000000 | USD |
CY2011 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
20000000 | USD |
CY2012 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
0 | USD |
CY2013 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
0 | USD |
CY2011 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
34000 | USD |
CY2012 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
8000 | USD |
CY2013 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
0 | USD |
CY2012Q4 | us-gaap |
Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
|
0 | USD |
CY2013Q4 | us-gaap |
Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
|
231000 | USD |
CY2012Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
0 | USD |
CY2013Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
9600000 | USD |
CY2011 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-8000 | USD |
CY2012 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-8000 | USD |
CY2013 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
0 | USD |
CY2011 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-126000 | USD |
CY2012 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
0 | USD |
CY2013 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
0 | USD |
CY2011 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
0 | USD |
CY2012 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-6000 | USD |
CY2013 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
12000 | USD |
CY2011 | acur |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
1076000 | USD |
CY2013 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
46800000 | USD |
CY2013Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
137600000 | USD |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | pure |
CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
300000 | USD |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
100000 | USD |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
13000 | USD |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
2700000 | USD |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
100000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
28000 | USD |
CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> Management is required to make certain estimates and assumptions in order to prepare consolidated financial statements in conformity with GAAP. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes.</font> <font style="FONT-SIZE: 10pt">Actual results could differ from those estimates. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based on such periodic evaluations.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2013 | acur |
Increase Decrease In Deferred Program Fee Revenue
IncreaseDecreaseInDeferredProgramFeeRevenue
|
0 | USD |
CY2011 | acur |
Proceeds From Issuance Of Common Stock Value Under Market Offerings
ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings
|
0 | USD |
CY2012 | acur |
Proceeds From Issuance Of Common Stock Value Under Market Offerings
ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings
|
0 | USD |
CY2013 | acur |
Proceeds From Issuance Of Common Stock Value Under Market Offerings
ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings
|
102000 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
400000 | USD |
CY2012Q4 | us-gaap |
Inventory Gross
InventoryGross
|
200000 | USD |
CY2013Q4 | us-gaap |
Inventory Gross
InventoryGross
|
500000 | USD |
CY2013Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
10000000 | USD |
CY2013Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.0835 | pure |
CY2013 | acur |
Payment Of Royalty Maximum Contractual Term
PaymentOfRoyaltyMaximumContractualTerm
|
P45D | |
CY2012Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2013Q1 | us-gaap |
Revenues
Revenues
|
4000 | USD |
CY2013Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1100000 | USD |
CY2012Q2 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2013Q4 | acur |
Debt Default Long Term Debt Percentage
DebtDefaultLongTermDebtPercentage
|
0.1335 | pure |
CY2013Q2 | us-gaap |
Revenues
Revenues
|
1000 | USD |
CY2012Q3 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2013Q3 | us-gaap |
Revenues
Revenues
|
83000 | USD |
CY2012Q4 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2011 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercises
|
935000 | shares |
CY2012 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercises
|
24000 | shares |
CY2013Q4 | us-gaap |
Revenues
Revenues
|
35000 | USD |
CY2013 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2018-12-01 | |
CY2012Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
2344000 | USD |
CY2013Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
3308000 | USD |
CY2013Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4248000 | USD |
CY2012Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2189000 | USD |
CY2013Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
3141000 | USD |
CY2012Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2149000 | USD |
CY2012Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
3057000 | USD |
CY2013Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
3516000 | USD |
CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2344000 | USD |
CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4244000 | USD |
CY2012Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2189000 | USD |
CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3140000 | USD |
CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2149000 | USD |
CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3225000 | USD |
CY2013 | acur |
Debt Instrument Amortization Date
DebtInstrumentAmortizationDate
|
2015-04-01 | |
CY2013 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercises
|
24000 | shares |
CY2011 | acur |
Taxes Withheld On Issuance Of Stock Based Awards
TaxesWithheldOnIssuanceOfStockBasedAwards
|
1300000 | USD |
CY2012 | acur |
Taxes Withheld On Issuance Of Stock Based Awards
TaxesWithheldOnIssuanceOfStockBasedAwards
|
31 | USD |
CY2013 | acur |
Taxes Withheld On Issuance Of Stock Based Awards
TaxesWithheldOnIssuanceOfStockBasedAwards
|
32 | USD |
CY2011 | acur |
Statutory Minimum Payroll Taxes
StatutoryMinimumPayrollTaxes
|
886 | USD |
CY2012 | acur |
Statutory Minimum Payroll Taxes
StatutoryMinimumPayrollTaxes
|
15 | USD |
CY2013 | acur |
Statutory Minimum Payroll Taxes
StatutoryMinimumPayrollTaxes
|
4 | USD |
CY2011 | acur |
Number Of Shares Issued On Cashless Exercises
NumberOfSharesIssuedOnCashlessExercises
|
383000 | shares |
CY2012 | acur |
Number Of Shares Issued On Cashless Exercises
NumberOfSharesIssuedOnCashlessExercises
|
9000 | shares |
CY2013 | acur |
Number Of Shares Issued On Cashless Exercises
NumberOfSharesIssuedOnCashlessExercises
|
6000 | shares |
CY2012Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3057000 | USD |
CY2013Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3481000 | USD |
CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2333000 | USD |
CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4218000 | USD |
CY2012Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2179000 | USD |
CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3076000 | USD |
CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2140000 | USD |
CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3190000 | USD |
CY2012Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3016000 | USD |
CY2013Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3417000 | USD |
CY2012Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | |
CY2013Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | |
CY2012 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
CY2013 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
CY2011 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
136000 | shares |
CY2012 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
CY2013 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
CY2013 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
300000 | USD |
CY2012Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | |
CY2013Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | |
CY2012Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
CY2013Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | |
CY2012Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.06 | |
CY2013Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | |
CY2012Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | |
CY2013 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
200000 | USD |
CY2013 | us-gaap |
Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
|
830000 | shares |
CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
250000 | USD |
CY2013 | acur |
Proceeds From Non Refundable Upfront Fees For Research And Development Arrangment Contract To Perform For Other
ProceedsFromNonRefundableUpfrontFeesForResearchAndDevelopmentArrangmentContractToPerformForOther
|
30000000 | USD |
CY2011 | us-gaap |
Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
|
500000 | USD |
CY2013 | us-gaap |
Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
|
300000 | USD |
CY2013 | us-gaap |
Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
|
30000000 | USD |
CY2008Q2 | us-gaap |
Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
|
3000000 | USD |
CY2011Q2 | acur |
Proceedds From Research And Development Contingent Consideration Payment
ProceeddsFromResearchAndDevelopmentContingentConsiderationPayment
|
20000000 | USD |
CY2013 | us-gaap |
Proceeds From Collaborators
ProceedsFromCollaborators
|
78500000 | USD |
CY2011 | us-gaap |
Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
|
100000 | USD |
CY2012 | us-gaap |
Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
|
100000 | USD |
CY2013 | us-gaap |
Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
|
100000 | USD |
CY2011 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldMinimumPayrollTaxes
|
324000 | shares |
CY2013Q4 | acur |
Restricted Stock Units Sale Price
RestrictedStockUnitsSalePrice
|
0.01 | |
CY2013Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | |
CY2012Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | |
CY2013Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | |
CY2012Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
CY2013Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | |
CY2012Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.06 | |
CY2013Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | |
CY2012 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldMinimumPayrollTaxes
|
10000 | shares |
CY2011 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
366000 | shares |
CY2013 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldMinimumPayrollTaxes
|
17000 | shares |
CY2011 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Statutory Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldStatutoryMinimumPayrollTaxes
|
228000 | shares |
CY2012 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Statutory Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldStatutoryMinimumPayrollTaxes
|
5000 | shares |
CY2013 | acur |
Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Statutory Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldStatutoryMinimumPayrollTaxes
|
1000 | shares |
CY2012 | acur |
Increase Decrease In Deferred Program Fee Revenue
IncreaseDecreaseInDeferredProgramFeeRevenue
|
0 | USD |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7476000 | USD |
CY2012Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
19946000 | USD |
CY2012Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
5000 | USD |
CY2012Q4 | us-gaap |
Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
|
36000 | USD |
CY2012Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
219000 | USD |
CY2012Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
43000 | USD |
CY2013Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
0 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Gross Current
DeferredTaxAssetsGrossCurrent
|
186000 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
941000 | USD |
CY2012Q4 | us-gaap |
Other Assets
OtherAssets
|
11000 | USD |
CY2012Q4 | us-gaap |
Assets
Assets
|
29059000 | USD |
CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
994000 | USD |
CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1424000 | USD |
CY2011 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
32000 | USD |
CY2012 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
79000 | USD |
CY2013 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
194000 | USD |
CY2011 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
0 | USD |
CY2012 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
0 | USD |
CY2013 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
4000 | USD |
CY2011 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2000 | USD |
CY2012 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
71000 | USD |
CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
189000 | USD |
CY2011 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
10532000 | USD |
CY2012 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-9668000 | USD |
CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-13901000 | USD |
CY2011 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
147000 | USD |
CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
27630000 | USD |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
629000 | USD |
CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
1429000 | USD |
CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9668000 | USD |
CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
10385000 | USD |
CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13901000 | USD |
CY2011 | us-gaap |
Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
|
0 | USD |
CY2012 | us-gaap |
Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
|
-40000 | USD |
CY2013 | us-gaap |
Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
|
59000 | USD |
CY2011 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
0 | USD |
CY2012 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-40000 | USD |
CY2013 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
59000 | USD |
CY2011 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
10385000 | USD |
CY2012 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-9708000 | USD |
CY2013 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-13842000 | USD |
CY2011 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.22 | |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
483000 | USD |
CY2012Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
362422000 | USD |
CY2013Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
366533000 | USD |
CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-335211000 | USD |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-349112000 | USD |
CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-40000 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17923000 | USD |
CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
29059000 | USD |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
28630000 | USD |
CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
459000 | USD |
CY2013Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
5000 | USD |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
27453000 | USD |
CY2012 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.20 | |
CY2013 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.29 | |
CY2011 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.22 | |
CY2012 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.20 | |
CY2013 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.29 | |
CY2011 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
47505000 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
47521000 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
47764000 | shares |
CY2011 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
48007000 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
47521000 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
47764000 | shares |
CY2013Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
13000000 | USD |
CY2012Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1900000 | shares |
CY2013Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2200000 | shares |
CY2012Q4 | acur |
Exercise Price Of Warrants
ExercisePriceOfWarrants
|
3.40 | |
CY2013Q4 | acur |
Exercise Price Of Warrants
ExercisePriceOfWarrants
|
3.15 | |
CY2012Q4 | acur |
Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
|
August 2014 | |
CY2013Q4 | acur |
Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
|
December 2020 | |
CY2011 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
45016000 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
45863000 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
46935000 | shares |
CY2011 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
2489000 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
1658000 | shares |
CY2011 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2805000 | shares |
CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5152000 | shares |
CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
413000 | USD |
CY2012Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
5000 | USD |
CY2013Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
287000 | USD |
CY2012Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
5000 | USD |
CY2013Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
0 | USD |
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
10707000 | USD |
CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
19000 | USD |
CY2013 | acur |
Percentage Of Royalty
PercentageOfRoyalty
|
0.05 | pure |
CY2013 | acur |
Percentage Of Royalty Deduct To Settle Third Party Claim
PercentageOfRoyaltyDeductToSettleThirdPartyClaim
|
0.5 | pure |
CY2013 | acur |
Percentage Of Royalty Of Royalty Payable Minimum
PercentageOfRoyaltyOfRoyaltyPayableMinimum
|
0.8 | pure |
CY2012Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
1200000 | USD |
CY2013Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
3100000 | USD |
CY2012Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
6300000 | USD |
CY2013Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
6800000 | USD |
CY2012Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
19900000 | USD |
CY2013Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
13700000 | USD |
CY2012Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
20000000 | USD |
CY2013Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
13700000 | USD |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.14 | pure |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.14 | pure |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.11 | pure |
CY2011 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.39 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.60 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.54 | |
CY2011 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
0 | USD |
CY2012 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
0 | USD |
CY2013 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
10000 | USD |
CY2012 | us-gaap |
Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
|
0 | USD |
CY2013 | us-gaap |
Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
|
0 | USD |
CY2012 | us-gaap |
Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
|
100000 | USD |
CY2013 | us-gaap |
Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
|
0 | USD |
CY2012Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
55000 | USD |
CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
78000 | USD |
CY2012Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
216000 | USD |
CY2013Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
293000 | USD |
CY2012Q4 | acur |
Other Accrued Taxes Current
OtherAccruedTaxesCurrent
|
5000 | USD |
CY2013Q4 | acur |
Other Accrued Taxes Current
OtherAccruedTaxesCurrent
|
1000 | USD |
CY2012Q4 | us-gaap |
Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
|
20000 | USD |
CY2013Q4 | us-gaap |
Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
|
15000 | USD |
CY2012Q4 | acur |
Manufacturing Services Costs
ManufacturingServicesCosts
|
21000 | USD |
CY2013Q4 | acur |
Manufacturing Services Costs
ManufacturingServicesCosts
|
14000 | USD |
CY2012Q4 | acur |
Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
|
21000 | USD |
CY2013Q4 | acur |
Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
|
0 | USD |
CY2012Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
75000 | USD |
CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
140000 | USD |
CY2011 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2458000 | USD |
CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1733000 | USD |
CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1215000 | USD |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0 | pure |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0 | pure |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0 | pure |
CY2011 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
0 | USD |
CY2012 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
0 | USD |
CY2013 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
113000 | USD |
CY2011 | us-gaap |
Revenues
Revenues
|
20466000 | USD |
CY2012 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2013 | us-gaap |
Revenues
Revenues
|
123000 | USD |
CY2011 | acur |
Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
|
0 | USD |
CY2012 | acur |
Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
|
0 | USD |
CY2013 | acur |
Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
|
114000 | USD |
CY2011 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
CY2012 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
CY2013 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
250000 | USD |
CY2011 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4037000 | USD |
CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3726000 | USD |
CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4923000 | USD |
CY2011 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5895000 | USD |
CY2012 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6013000 | USD |
CY2013 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8926000 | USD |
CY2013 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
829000 | shares |
CY2013 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
14213000 | USD |
CY2011 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
217000 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
9000 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
9000 | USD |
CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24341000 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2458000 | USD |
CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1733000 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1215000 | USD |
CY2011 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
1000 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
1000 | USD |
CY2013 | acur |
Issuance Of Common Stock Value Under Market Offerings
IssuanceOfCommonStockValueUnderMarketOfferings
|
3226000 | USD |
CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5892000 | shares |
CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
36643000 | USD |
CY2011 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
131000 | USD |
CY2012 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
131000 | USD |
CY2013 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
134000 | USD |
CY2012 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
0 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-238000 | USD |
CY2011 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
-77000 | USD |
CY2012 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
0 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
-185000 | USD |
CY2011 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
626000 | USD |
CY2012 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
473000 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
369000 | USD |
CY2011 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
-55000 | USD |
CY2012 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
2000 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
2000 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
1758000 | USD |
CY2011 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-3863000 | USD |
CY2012 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
2812000 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
4742000 | USD |
CY2012Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2597000 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2617000 | USD |
CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1545000 | USD |
CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1676000 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
0 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
2522000 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
2741000 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
2979000 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
|
0 | USD |
CY2013Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
10000000 | USD |
CY2013Q4 | us-gaap |
Secured Debt
SecuredDebt
|
10000000 | USD |
CY2013 | us-gaap |
Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
|
298000 | shares |
CY2013Q4 | us-gaap |
Share Price
SharePrice
|
1.595 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
26674000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
548000 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
-443000 | shares |
CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
46830000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
4434000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
2843000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
887000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
1433000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
3486000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
-15000 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
2.77 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.54 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2261000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
-20000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
119000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
2.75 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
2.17 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.71 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
623000 | shares |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.019 | pure |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.017 | pure |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.019 | pure |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.034 | pure |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.020 | pure |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.029 | pure |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
533000 | shares |
CY2011 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
3510000 | USD |
CY2012 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-3287000 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-4690000 | USD |
CY2011 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
6000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
35461000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
53486000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
35461000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
53486000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2011 | acur |
Program Fee Revenue
ProgramFeeRevenue
|
466000 | USD |
CY2012 | acur |
Program Fee Revenue
ProgramFeeRevenue
|
0 | USD |
CY2013 | acur |
Program Fee Revenue
ProgramFeeRevenue
|
0 | USD |
CY2011 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD |
CY2012 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD |
CY2013 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
9000 | USD |
CY2011 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1076000 | USD |
CY2012 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
-231000 | USD |
CY2013 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
CY2011 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
0 | USD |
CY2013 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
10000000 | USD |
CY2011 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | USD |
CY2011 | acur |
Increase Decrease In Deferred Program Fee Revenue
IncreaseDecreaseInDeferredProgramFeeRevenue
|
466000 | USD |
CY2013 | acur |
Debt Instrument Deferment Of Amortization Date Description
DebtInstrumentDefermentOfAmortizationDateDescription
|
The Amortization Date is April 1, 2015, but shall automatically become April 1, 2016 if the Company achieves 75% of its projected Nexafed cash receipts and 75% of its projected Oxecta cash receipts for the fiscal year ending December 31, 2014 (collectively, the First Revenue Event). | |
CY2013 | acur |
Debt Instrument Further Deferment Of Amortization Date Description
DebtInstrumentFurtherDefermentOfAmortizationDateDescription
|
The Amortization Date will be further deferred until April 1, 2017 if the First Revenue Event occurs and in addition the Company achieves 75% of its projected Nexafed cash receipts and 75% of its projected Oxecta cash receipts for the fiscal year ending December 31, 2015 (collectively, the Second Revenue Event). | |
CY2013Q4 | us-gaap |
Debt Instrument Fee Amount
DebtInstrumentFeeAmount
|
50000 | USD |
CY2013 | acur |
Debt Consulting Placement Fee
DebtConsultingPlacementFee
|
100000 | USD |
CY2013 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
231000 | USD |
CY2013 | acur |
Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
|
298000 | shares |
CY2013Q4 | acur |
Warrants Exercise Price
WarrantsExercisePrice
|
1.595 | |
CY2013Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
400000 | USD |
CY2013 | acur |
Warrants Expiry Date
WarrantsExpiryDate
|
2020-12-27 | |
CY2012Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
400000 | USD |
CY2013Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
10000000 | USD |
CY2013Q4 | acur |
Research And Development Arrangement Contract To Perform For Others Expenses Receivable
ResearchAndDevelopmentArrangementContractToPerformForOthersExpensesReceivable
|
360000 | USD |
CY2011 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
2800000 | USD |
CY2012 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
2800000 | USD |
CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
18000000 | USD |
CY2013 | us-gaap |
State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
|
2800000 | USD |